Search Results - "Hense, J."

Refine Results
  1. 1

    Fatigue, barriers to physical activity and predictors for motivation to exercise in advanced Cancer patients by Frikkel, J, Götte, M, Beckmann, M, Kasper, S, Hense, J, Teufel, M, Schuler, M, Tewes, M

    Published in BMC palliative care (31-03-2020)
    “…In order to counteract fatigue, physical activity (PA) is recommended for all stages of cancer. However, only few advanced cancer patients (ACP) are physically…”
    Get full text
    Journal Article
  2. 2

    Palliative care outpatients in a German comprehensive cancer center-identifying indicators for early and late referral by Müller, S, Fink, M, Hense, J, Comino, M R Salvador, Schuler, M, Teufel, M, Tewes, M

    Published in BMC palliative care (12-12-2022)
    “…Despite that early integration of palliative care is recommended in advanced cancer patients, referrals to outpatient specialised palliative care (SPC)…”
    Get full text
    Journal Article
  3. 3

    Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin by Alberti, P., Rossi, E., Cornblath, D.R., Merkies, I.S.J., Postma, T.J., Frigeni, B., Bruna, J., Velasco, R., Argyriou, A.A., Kalofonos, H.P., Psimaras, D., Ricard, D., Pace, A., Galiè, E., Briani, C., Dalla Torre, C., Faber, C.G., Lalisang, R.I., Boogerd, W., Brandsma, D., Koeppen, S., Hense, J., Storey, D., Kerrigan, S., Schenone, A., Fabbri, S., Valsecchi, M.G., Cavaletti, G., Cavaletti, G., Cornblath, D.R., Merkies, I.S.J., Postma, T.J., Valsecchi, M.G, Galimberti, S., Rossi, E., Frigeni, B., Lanzani, F., Mattavelli, L., Piatti, M.L., Alberti, P., Binda, D., Bidoli, P., Cazzaniga, M., Cortinovis, D., Bruna, J., Velasco, R., Argyriou, A.A., Kalofonos, H.P., Psimaras, D., Ricard, D., Pace, A., Galiè, E., Briani, C., Lucchetta, M., Campagnolo, M., Dalla Torre, C., Faber, C.G., Vanhoutte, E.K., Bakkers, M., Brouwer, B., Lalisang, R.I., Boogerd, W., Brandsma, D., Koeppen, S., Hense, J., Grant, R., Storey, D., Kerrigan, S., Schenone, A., Reni, L., Piras, B., Fabbri, S., Padua, L., Granata, G., Leandri, M., Ghignotti, I., Plasmati, R., Pastorelli, F., Heimans, J.J., Eurelings, M., Meijer, R.J., Grisold, W., Lindeck Pozza, E., Mazzeo, A., Toscano, A., Tomasello, C., Altavilla, G., Penas Prado, M., Dominguez Gonzalez, C., Dorsey, S.G., Brell, J.M.

    Published in Annals of oncology (01-01-2014)
    “…The different perception and assessment of chemotherapy-induced peripheral neurotoxicity (CIPN) between healthcare providers and patients has not yet been…”
    Get full text
    Journal Article
  4. 4

    PARPACT: Paramedic Palliative Care Test : Validation of a questionnaire to assess palliative care knowledge and self-efficacy expectations of paramedics by Chwallek, D, Schweda, A, Neukirchen, M, Hense, J, Schwartz, J, Mallmann, B, Teufel, M, Schuler, M, Tewes, Mitra

    Published in Schmerz (Berlin, Germany) (01-10-2022)
    “…Given the large number of palliative patients cared for by the emergency services, education and training in palliative care topics are playing an increasingly…”
    Get full text
    Journal Article
  5. 5

    Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months—a comparative study by Frikkel, J., Beckmann, M., De Lazzari, N., Götte, M., Kasper, S., Hense, J., Schuler, M., Teufel, M., Tewes, M.

    Published in Supportive care in cancer (01-09-2021)
    “…Purpose Physical activity (PA) is recommended to improve advanced cancer patients’ (ACP) physical functioning, fatigue, and quality of life. Yet, little is…”
    Get full text
    Journal Article
  6. 6
  7. 7

    11C–MET PET/MRI for detection of recurrent glioma by Deuschl, C., Kirchner, J., Poeppel, T. D., Schaarschmidt, B., Kebir, S., El Hindy, N., Hense, J., Quick, H. H., Glas, M., Herrmann, K., Umutlu, L., Moenninghoff, C., Radbruch, A., Forsting, M., Schlamann, M.

    “…Introduction Radiological assessment of brain tumors is widely based on the Radiology Assessment of Neuro-Oncology (RANO) criteria that consider non-specific…”
    Get full text
    Journal Article
  8. 8

    Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide: case report and literature review by Hansen, Niels, Wittig, A, Hense, J, Kastrup, O, Gizewski, E R, Van de Nes, J A P

    Published in European journal of medical research (12-09-2011)
    “…Primary diffuse leptomeningeal gliomatosis (PDLG) is a rare neoplasm with a short survival time of a few months. There is currently no standardized therapeutic…”
    Get full text
    Journal Article
  9. 9

    Administration of Gemcitabine for Metastatic Adenocarcinoma during Pregnancy: A Case Report and Review of the Literature by Wiesweg, M, Aydin, S, Koeninger, A, Stein, A, Schara, U, van Roye, C, Hense, J, Welt, A, Schuler, M

    Published in American journal of perinatology reports (01-05-2014)
    “…We present the case of a 38-year-old woman diagnosed with metastatic adenocarcinoma of the biliary tract in the 18th week of pregnancy. Chemotherapy based on…”
    Get full text
    Journal Article
  10. 10

    Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution by Müller, S, Schütt, P, Bojko, P, Nowrousian, M R, Hense, J, Seeber, S, Moritz, T

    Published in Annals of hematology (01-02-2005)
    “…Hemolytic uremic syndrome (HUS) has been described following the administration of multiple antineoplastic agents, most notably mitomycin C. More recently,…”
    Get full text
    Journal Article
  11. 11

    Multivisceral systemic metastases from an intracranial anaplastic meningioma: A case report and review of literature by Lambertz, N, Koehler, J, Schulte, D.M, Kuehl, H, Wohlschlaeger, J, Hense, J, Schuler, M, Mueller, O.M

    Published in Clinical neurology and neurosurgery (01-09-2011)
    “…Overall, metastases are more likely in recurrent tumors and seem to be rare in primary tumors [10,12,15,16]. [...]the risk of metastatic spread apparently…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma by Schütt, P., Ebeling, P., Buttkereit, U., Brandhorst, D., Opalka, B., Hoiczyk, M., Flasshove, M., Hense, J., Bojko, P., Metz, K., Moritz, T., Seeber, S., Nowrousian, M. R.

    Published in European journal of haematology (01-01-2005)
    “…:  The present study aimed to evaluate the side‐effects and efficacy of thalidomide in combination with an anthracycline‐containing chemotherapy regimen in…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    P08.46 Rechallenge with bevacizumab in a long-term survivor with glioblastoma by Koeppen, S., Hense, J.

    Published in Neuro-oncology (Charlottesville, Va.) (01-10-2016)
    “…The prognosis of patients with glioblastoma multiforme (GBM, WHO grade IV), the most common primary brain tumor in adults, is generally poor with median…”
    Get full text
    Journal Article
  20. 20